Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Yasaman, Damestani"'
Autor:
Bohdana Ratitch, Isaac R. Rodriguez-Chavez, Abhishek Dabral, Adriano Fontanari, Julio Vega, Francesco Onorati, Benjamin Vandendriessche, Stuart Morton, Yasaman Damestani
Publikováno v:
Digital Biomarkers, Vol 6, Iss 3, Pp 83-97 (2022)
Background: The proliferation and increasing maturity of biometric monitoring technologies allow clinical investigators to measure the health status of trial participants in a more holistic manner, especially outside of traditional clinical settings.
Externí odkaz:
https://doaj.org/article/3aa3e58c41e44a758acacb65bd37d482
Autor:
Bohdana Ratitch, Elizabeth Kunkoski, Adriano Fontanari, Francesco Onorati, Abhishek Dabral, Isaac R. Rodriguez-Chavez, Benjamin Vandendriessche, Julio Vega, Stuart Morton, Yasaman Damestani
UNSTRUCTURED The proliferation and increasing maturity of biometric monitoring technologies allows clinical investigators to measure the health status of trial participants in a more holistic manner, especially outside of clinical settings. This incl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6928b31e1c75acb16408c8266e7be096
https://doi.org/10.2196/preprints.36410
https://doi.org/10.2196/preprints.36410
Autor:
Howard Colman, Frances Chow, Jatin P. Shah, Gregory Mundy, Andrew B. Lassman, Rebecca Harrison, Yasaman Damestani, Yang Liu, Vyshak Venur, Warren P. Mason, Nicholas Butowski, Minesh P. Mehta, Paul Duic, Sharon Tamir, Michael Schulder, John A. Boockvar, Kai Li, Yazmin Odia, Patrick Y. Wen, Erin M. Dunbar, Samuel Goldlust, Sharon Shacham, Scott R. Plotkin, Eric Sbar, Priya Kumthekar
Publikováno v:
Neuro Oncol
BACKGROUND Glioblastoma (GBM) is the most common and aggressive primary brain tumor with median overall survival of 15 months and 5-7 months for patients with newly diagnosed or recurrent disease (nGBM or rGBM), respectively. Selinexor is a first-in-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11df5e902dd159ffa4583cceaf50b1be
https://doi.org/10.1093/neuonc/noab196.242
https://doi.org/10.1093/neuonc/noab196.242
Autor:
Yasaman Damestani, Ruiyang Shi, Kai Li, Patrice Melikian, Shelley Haybeck, Gregory Mundy, Gursharan Gill, Shijie Tang, Eric Sbar, Tracey Duncan, Sharon Tamir, Eran Shacham, Jatin J. Shah, Sharon Shacham, Patrick Y. Wen, Erin Dunbar, Priya Kumthekar, Howard Colman, Robert Aiken, Nicholas A. Butowski
Publikováno v:
Journal of Clinical Oncology. 40:2045-2045
2045 Background: Glioblastoma (GBM) is an aggressive primary tumor with poor prognosis and survival. Patients (pts) experience debilitating symptoms that have a negative effect on quality of life (QoL). A multidisciplinary approach is necessary to fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf0f9a2c67258834d962d4814f65efc1
https://doi.org/10.1200/jco.2022.40.16_suppl.2045
https://doi.org/10.1200/jco.2022.40.16_suppl.2045
Autor:
Yang Liu, Andreas F. Hottinger, Sharon Shacham, Yasaman Damestani, Louis B. Nabors, Patrick Y. Wen, Eran Shacham, Sharon Tamir, Andrew B. Lassman, Minesh P. Mehta, Howard Colman, Shijie Tang, Michael Weller, Kevin Camphausen, Evanthia Galanis, Kai Li, Jatin J. Shah, Martin J. van den Bent, J. Paul Duic, John de Groot
Publikováno v:
Journal of Clinical Oncology. 39:2016-2016
2016 Background: Among the primary aims of new therapies for glioblastoma (GBM) are the reduction of morbidity and restoration or preservation of quality of life (QoL). Selinexor (SEL) is a first-in class, oral, selective inhibitor of nuclear export
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e35df4a09ca0812c3ccd5492352af6f1
https://doi.org/10.1200/jco.2021.39.15_suppl.2016
https://doi.org/10.1200/jco.2021.39.15_suppl.2016
Publikováno v:
Lasers in Surgery and Medicine. 48:782-789
Background and Objective The development and feasibility of a novel nanocrystalline yttria-stabilized-zirconia (nc-YSZ) cranial implant has been recently established. The purpose of what we now call “window to the brain (WttB)” implant (or platfo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29fa6bca5a0a421241ec2fa3612e6387
https://doi.org/10.1002/lsm.22558
https://doi.org/10.1002/lsm.22558
Publikováno v:
Lasers in Surgery and Medicine. 46:488-498
Background and Objective Optical clearing agents (OCAs) have shown promise for increasing the penetration depth of biomedical lasers by temporarily decreasing optical scattering within the skin. However, their translation to the clinic has been const
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3aac293149ec6ae044aa69ae01b1dc0a
https://doi.org/10.1002/lsm.22258
https://doi.org/10.1002/lsm.22258
Autor:
Yasaman Damestani, Masaru P. Rao, Mike S. Hsu, Yasuhiro Kodera, B. Hyle Park, Devin K. Binder, Guillermo Aguilar, Jenny I. Szu, Carissa L. Reynolds, Javier E. Garay
Publikováno v:
Nanomedicine : nanotechnology, biology, and medicine, vol 9, iss 8
Damestani, Y; Reynolds, CL; Szu, J; Hsu, MS; Kodera, Y; Binder, DK; et al.(2013). Transparent nanocrystalline yttria-stabilized-zirconia calvarium prosthesis. Nanomedicine: Nanotechnology, Biology, and Medicine, 9(8), 1135-1138. doi: 10.1016/j.nano.2013.08.002. UC Riverside: Retrieved from: http://www.escholarship.org/uc/item/0th8v0p9
Damestani, Y; Reynolds, CL; Szu, J; Hsu, MS; Kodera, Y; Binder, DK; et al.(2013). Transparent nanocrystalline yttria-stabilized-zirconia calvarium prosthesis. Nanomedicine: Nanotechnology, Biology, and Medicine, 9(8), 1135-1138. doi: 10.1016/j.nano.2013.08.002. UC Riverside: Retrieved from: http://www.escholarship.org/uc/item/0th8v0p9
Laser-based diagnostics and therapeutics show promise for many neurological disorders. However, the poor transparency of cranial bone (calvaria) limits the spatial resolution and interaction depth that can be achieved, thus constraining opportunity i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97dcd8daa6df98c4dbe3a347d39a4c20
https://doi.org/10.1016/j.nano.2013.08.002
https://doi.org/10.1016/j.nano.2013.08.002
Autor:
Yasaman, Damestani, Natalie, De Howitt, David L, Halaney, Javier E, Garay, Guillermo, Aguilar
Publikováno v:
Lasers in surgery and medicine. 48(8)
The development and feasibility of a novel nanocrystalline yttria-stabilized-zirconia (nc-YSZ) cranial implant has been recently established. The purpose of what we now call "window to the brain (WttB)" implant (or platform), is to improve patient ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e36c12d93e91921724b3ee163a0d80ec
https://pubmed.ncbi.nlm.nih.gov/27389389
https://pubmed.ncbi.nlm.nih.gov/27389389
Publikováno v:
Nanomedicine : nanotechnology, biology, and medicine, vol 12, iss 7
The long-range goal of the windows to the brain (WttB) is to improve patient care by providing a technique for delivery and/or collection of light into/from the brain, on demand, over large areas, and on a chronically-recurring basis without the need
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce55721fb71eab0a7670034211eee27b
https://pubmed.ncbi.nlm.nih.gov/27133190
https://pubmed.ncbi.nlm.nih.gov/27133190